Armstrong, Terri S.

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 2,834

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., et al. (2013) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 1,063

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., Armstrong, T. S., Sulman, E. P., Cahill, D. P., Vera-Bolanos, E., et al. (2015) · Acta Neuropathologica

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 354

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., et al. (2013) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 70

Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review

Brady, V. J., Grimes, D., Armstrong, T., & LoBiondo-Wood, G. (2014) · Oncology nursing forum

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research

Cited by 31